Sangamo Therapeutics (SGMOQ) Deferred Taxes (2015 - 2025)

Sangamo Therapeutics has reported Deferred Taxes for 5 years, with the latest figure at $15000.0 in Q1 2025.

• On a quarterly basis, Deferred Taxes changed N/A year-over-year to $15000.0 in Q1 2025; TTM through Mar 2025 was $15000.0, a 64.29% decrease from a year earlier, with the FY2023 full-year figure at -$6.3 million, changed N/A from the prior year.
• Deferred Taxes was $15000.0 for Q1 2025 at Sangamo Therapeutics, up from -$18000.0 in the prior quarter.
• The five-year high for Deferred Taxes was $182000.0 in Q3 2023, with the low at -$140000.0 in Q4 2023.
• Average Deferred Taxes over 3 years is $11400.0, with a median of $15000.0 recorded in 2025.
• The largest YoY upside for Deferred Taxes was 87.14% in 2024 against a maximum downside of 90.11% in 2024.
• Over 3 years, Deferred Taxes stood at -$140000.0 in 2023, then soared by 87.14% to -$18000.0 in 2024, then soared by 183.33% to $15000.0 in 2025.
• The last three Deferred Taxes figures came in at $15000.0 (Q1 2025), -$18000.0 (Q4 2024), and $18000.0 (Q3 2024), per Business Quant data.